Prostate cancer screening and mortality: A case-control study (United States)

Cancer Causes and Control

Volumn 15, Issue 2, 2004, Pages 133-138

  Weinmann, Sheila ^a   Richert Boe, Kathryn ^a   Glass, Andrew G ^a   Weiss, Noel S ^b  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Case control studies; Epidemiology; Mass screening; Prostate neoplasms; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CASE CONTROL STUDY; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; DYING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; UNITED STATES;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PHYSICAL EXAMINATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RANDOM ALLOCATION; RISK FACTORS; UNITED STATES;

EID: 1842430177     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CACO.0000019473.83472.18     Document Type: Article

References (19)

1. Jemal A, Murray T, Samuels A, et al. (2003) Cancer Statistics, 2003. CA Cancer J Clin 53: 5-26.
2. Gohagan JD, Prorok PC, Kramer BS, et al. (1995) The prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute. Cancer 75(suppl 7): 1869-1873.
3. de Koning HJ, Auvinen A, Berenguer Sanchez A, et al. (2002) Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial. Int J Cancer 97: 237-244.
4. ERSPC (2002) Prostate cancer mortality reduction by screening: power and time frame with complete enrollment in the European Randomised Screening for prostate Cancer (ERSPC) trial. Int J Cancer 98: 268-273.
5. Clarke EA, Anderson TW (1979) Does screening by 'Pap' smears help prevent cervical cancer? A case-control study. Lancet 314: 1-4.
6. IARC Working Group (1986) Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. BMJ 293: 659-664.
7. Verbeek ALM, Hendriks JHCL, Holland R, et al. (1984) Reduction of breast cancer mortality through mass screening with modern mammography. Lancet 323: 1222-1224.
8. Palli D, Del Turco MR, Buiatti E, et al. (1986) A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). Int J Cancer 38: 501-504.
9. Ebeling K, Nischan P (1987) Screening for lung cancer: results from a case-control study. Int J Cancer 40: 141-144.
10. Sovue T, Suzuki T, Naruke T (1992) Japanese Lung Cancer Screening Research Group: a case-control study for evaluating lung-cancer screening in Japan. Int J Cancer 50: 230-237.
11. Selby JV, Friedman GD, Quesenberry CP, et al. (1993) Effect of fecal occult blood testing on mortality from colorectal cancer: a case-control study. Ann Int Med 118: 1-6.
12. Lazovich D, Weiss NS, Stevens HG, et al. (1996) A case-control study to evaluate efficacy of screening for faecal occult blood. J Med Screen 2: 84-89.
13. Selby JV, Friedman GD, Quesenberry CP, et al. (1992) A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. NEJM 326: 653-657.
14. Newcomb PA, Norfleet RG, Storer BE, et al. (1992) Screening sigmoidoscopy and colorectal cancer mortality. JNCI 84: 1572-1575.
15. Friedman GD, Hiatt RA, Quesenberry CP Jr, et al. (1991) Case-control study of screening for prostatic cancer by digital rectal examinations. Lancet 337: 1526-1529.
16. Richert-Boe KA, Humphrey LL, Glass AG, et al. (1998) Screening digital rectal examination and prostate cancer mortality: a case-control study. J Med Screen 5: 99-103.
17. Jacobsen SJ, Bergstralh EJ, Katusic SK, et al. (1998) Screening digital rectal examination and prostate cancer mortality: a population-based case-control study. Urology 52: 173-179.
18. Weiss NS, McKnight B, Stevens NH (1992) Approaches to the analysis of case-control studies of the efficacy of screening for cancer. Am J Epidemiol 135: 817-823.
19. Weiss NS, Dhillon P (in press). The validity of case-control studies of the efficacy of cancer screening: overcoming non-random patterns of screening in the source population. Epidemiology.